Ocrelizumab shows the highest association with urinary tract infections in patients with MS according to an FDA Adverse Event ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results